posted on 2007-11-13, 00:00authored byM. Firouz Mohd Mustapa, Paul C. Bell, Christopher A. Hurley, Alastair Nicol, Erwann Guénin, Supti Sarkar, Michele J. Writer, Susie E. Barker, John B. Wong, Michael A. Pilkington-Miksa, Brigitte Papahadjopoulos-Sternberg, Parviz Ayazi Shamlou, Helen C. Hailes, Stephen L. Hart, Daniel Zicha, Alethea B. Tabor
Nonviral gene delivery vectors now show good therapeutic potential: however, detailed
characterization of the composition and macromolecular organization of such particles remains a challenge.
This paper describes experiments to elucidate the structure of a ternary, targeted, lipopolyplex synthetic
vector, the LID complex. This consists of a lipid component, Lipofectin (L) (1:1 DOTMA:DOPE), plasmid
DNA (D), and a dual-function, cationic peptide component (I) containing DNA condensation and integrin-targeting sequences. Fluorophore-labeled lipid, peptide, and DNA components were used to formulate
the vector, and the stoichiometry of the particles was established by fluorescence correlation spectroscopy
(FCS). The size of the complex was measured by FCS, and the sizes of LID, L, LD, and ID complexes
were measured by dynamic light scattering (DLS). Fluorescence quenching experiments and freeze−fracture electron microscopy were then used to demonstrate the arrangement of the lipid, peptide, and
DNA components within the complex. These experiments showed that the cationic portion of the peptide,
I, interacts with the plasmid DNA, resulting in a tightly condensed DNA−peptide inner core; this is
surrounded by a disordered lipid layer, from which the integrin-targeting sequence of the peptide partially
protrudes.